Rockwell Medical, Inc. (DE) Common Stock earnings per share and revenue
On 12 nov. 2025, RMTI reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -8.93% surprise. Revenue reached 15.93 million, compared to an expected 16.57 million, with a -3.86% difference. The market reacted with a -9.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analystes forecast an EPS of -0.04 USD, with revenue projected to reach 16.88 million USD, implying an baisse of -20.00% EPS, and hausse of 5.98% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08 janv. 2026 Pour Q2 26
Estimation
$0.05
Actuel
$0.10
Surprise
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08 janv. 2026 Pour Q2 26
Estimation
-$0.20
Actuel
-$0.41
Surprise
-100.98%
FAQ
What were Rockwell Medical, Inc. (DE) Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Rockwell Medical, Inc. (DE) Common Stock reported EPS of -$0.05, missing estimates by -8.93%, and revenue of $15.93M, -3.86% below expectations.
How did the market react to Rockwell Medical, Inc. (DE) Common Stock's Q3 2025 earnings?
The stock price moved down -9.04%, changed from $1.05 before the earnings release to $0.96 the day after.
When is Rockwell Medical, Inc. (DE) Common Stock expected to report next?
The next earning report is scheduled for 18 mars 2026.
What are the forecasts for Rockwell Medical, Inc. (DE) Common Stock's next earnings report?
Based on 4
analystes, Rockwell Medical, Inc. (DE) Common Stock is expected to report EPS of -$0.04 and revenue of $16.88M for Q4 2025.